AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 156 filers reported holding AMNEAL PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $567,037 | +30.5% | 134,369 | -4.2% | 0.07% | +37.5% |
| Q2 2023 | $434,629 | +110.3% | 140,203 | -5.7% | 0.05% | +92.0% |
| Q1 2023 | $206,703 | -30.2% | 148,707 | 0.0% | 0.02% | -32.4% |
| Q4 2022 | $295,927 | -1.4% | 148,707 | 0.0% | 0.04% | -28.8% |
| Q3 2022 | $300,000 | -36.6% | 148,707 | 0.0% | 0.05% | -54.8% |
| Q2 2022 | $473,000 | -23.7% | 148,707 | 0.0% | 0.12% | -8.7% |
| Q1 2022 | $620,000 | -56.5% | 148,707 | -50.0% | 0.13% | -13.7% |
| Q4 2021 | $1,424,000 | +79.3% | 297,414 | +100.0% | 0.15% | -15.6% |
| Q3 2021 | $794,000 | -67.3% | 148,707 | -68.7% | 0.17% | -60.4% |
| Q2 2021 | $2,431,000 | +1382.3% | 474,752 | +1849.5% | 0.44% | +1356.7% |
| Q1 2021 | $164,000 | -78.3% | 24,352 | -85.3% | 0.03% | -81.4% |
| Q4 2020 | $757,000 | -22.5% | 165,598 | -34.2% | 0.16% | -37.8% |
| Q3 2020 | $977,000 | -14.7% | 251,696 | +4.6% | 0.26% | -11.0% |
| Q2 2020 | $1,146,000 | +73.1% | 240,680 | +26.6% | 0.29% | +43.3% |
| Q1 2020 | $662,000 | – | 190,184 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 21,521,301 | $83,503,000 | 7.34% |
| Eversept Partners, LP | 2,656,208 | $10,306,087 | 2.29% |
| TPG Group Holdings (SBS) Advisors, Inc. | 16,213,367 | $62,908,000 | 1.13% |
| Prosight Management, LP | 512,659 | $1,989,000 | 0.95% |
| THB ASSET MANAGEMENT | 833,104 | $3,232,000 | 0.90% |
| GLOBEFLEX CAPITAL L P | 251,696 | $977,000 | 0.26% |
| XTX MARKETS LLC | 10,243 | $40,000 | 0.19% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 102,000 | $396,000 | 0.10% |
| PA Capital LLC | 33,874 | $132,000 | 0.09% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 60,900 | $236,000 | 0.07% |